Abstract:Annals of Otology, Rhinology &Laryngology, Ahead of Print. Objective:Tracheal transplantation could be a better option for patients with long segmental laryngotracheal stenosis or defects, but the need for immunosuppressants limits its widespread use due to the antigenicity of the tracheal epithelium. Chemically treated or cryopreserved nonviable tracheal allografts have no immunogenicity but lead to necrosis and stenosis in long-term outcomes. The present report describes the 5-year outcomes of de-epithelialized viable tracheal allotransplantation without immunosuppressants in a patient with severe laryngotracheal stenosis.Methods:The recipient was a 47-year-old female with relapsing polychondritis affecting the larynx and cervical trachea and producing a 5 cm long stenosis that could not be repaired using resection and anastomosis. A tracheal allograft was obtained from a 45-year-old male donor and treated with a combination of 3% sodium dodecyl sulfate (SDS) and organ preservation solution for 138 hours. The allograft was revascularized by heterotopical implantation in the infrahyoid muscles of the recipient for 3 months and then transplantation to the laryngotracheal defect with a split-thickness skin graft sutured to the lumen and a silicon T-tube. No immunosuppressants were used postoperatively.Results:The allograft was de-epithelialized, and most of the cartilage rings remained viable after the treatment. The allograft was revascularized, viable, and mechanically stable after 3 months of heterotopic implantation. No apparent signs of rejection or destruction were observed. The T-tube was removed, and the internal lining of the allograft was repopulated 4 months after orthotopic transplantation, despite the skin graft necrotizing at 2 weeks. Endoscopy and computed tomography showed a patent airway 5 years after orthotopic transplantation. The patient was able to resume her usual quality of life.Conclusion:The present study demonstrates that transplantation of the de-epithelialized viable tracheal allograft without immunosuppressants is safe and promising for patients with long laryngotracheal stenosis or defects, especially for those with malignant tumor resections.

Trachea Defect Reconstruction in Head and Neck Neoplasm Operation

Superficial Temporal Artery Flap: a New Option for Posterior Hypopharyngeal Wall Reconstruction

Traumatic laryngotracheal stenosis treated by hyoid-sternohyoid osseomuscular flap combined with xenogenic acellular dermal matrix: A case report and literature review.

Fortification strategies to meet micronutrient needs: sucesses and failures

Tracheal Carina Reconstruction and Bronchoplasty in the Treatment of 94 Central Type Bronchogenic Carcinomas

[On the diagnostic-therapeutic problems of intracranial arachnoiditic processes].

Carbon-carbon materials and composites for experimental tracheal reconstruction

[The clinical treatment of laryngotracheal rupture injury]

Regionalizing Canadian healthcare: the good--the bad--the ugly.

Tracheobronchial Segmental Resection and Reconstruction Applied to Surgical Treatment of Esophageal Cancer with Airway Involvement

Troubleshooting time-dependent density-functional theory for photochemical applications: oxirane.

Reconstruction of the Lower Trachea Using a Pedicled Autologous Bronchial Flap

Significance of Laryngo-tracheal flap to reconstruct the defect and management of pharyngoesophageal stenosis after resection of the hypopharyngeal carcinoma with cervical esophagus involvement

Surgical Management of Papillary Thyroid Carcinoma with Endotracheal Infiltration

Experimental reconstruction of canine trachea with free jejunal graft coupled with titanium-nickel alloy mesh

Avascular necrosis after surgical treatment for developmental dysplasia of the hip

Tracheal sleeve pneumonectomy for bronchogenic carcinoma invading the carina

Treatment of 40 patients with primary tracheal carcinoma

Subtotal Laryngectomy and Reconstruction of Laryngeal Function in the Treatment for T_2&T_3 Glottis Carcinoma

De-Epithelialized Viable Tracheal Allotransplantation Without Immunosuppressants: 5-Year Follow-Up

[Surgical treatment of primary malignant tumors of the trachea and main bronchus]